David Trexler

David Trexler Email and Phone Number

C-Suite Executive - BioPharma | Cancer Therapies | Patient Centric | Commercial Business Growth | Product Launch @ ONO PHARMA USA, INC.
David Trexler's Location
Boston, Massachusetts, United States, United States
David Trexler's Contact Details

David Trexler work email

David Trexler personal email

n/a

David Trexler phone numbers

About David Trexler

I am an inspirational leader that launches commercial strategies for global pharma and U.S. biotech start-ups. I accomplish this by creating innovative cultures, building and transforming companies, establishing a patient-centric focus, and developing deep partnerships and high performing teams. I have built commercial footprints for global pharma companies, launched novel drugs, and stood up a US biopharma affiliate that introduced a breakthrough immuno-oncology therapy. I am deeply committed to human health and the development of transformational cancer therapies. Below are highlights of my career accomplishments and specialties:- Solidified the organization’s strategic intent by establishing a clear vision and foundation to achieve launch readiness.- Built the first commercial operation for an oncology biotech, which led to a successful launch with early FDA approval.- Utilized established oncology networks to source top talent across functions and developed engaged teams to foster a performance-based culture.- Collaborated with cross-functional teams to fine-tune investment thesis to ensure optimal resource allocation.- Leveraged deep market insights including full customer segmentation by architype to quickly gain market share.Specialties: Global Experience | Commercial Strategies | Organizational Growth | Business Transformation | Product Launch | Health Care Innovation | Cancer Therapies | Patient Care | Marketing | Sales | Business Development | Business Analytics | P&L Management | Revenue Generation | Cross-Functional Team Leadership | Board Member

David Trexler's Current Company Details
ONO PHARMA USA, INC.

Ono Pharma Usa, Inc.

View
C-Suite Executive - BioPharma | Cancer Therapies | Patient Centric | Commercial Business Growth | Product Launch
David Trexler Work Experience Details
  • Ono Pharma Usa, Inc.
    Chief Commercial Officer And Us Board Member
    Ono Pharma Usa, Inc. 2021 - Present
    Cambridge, Massachusetts, Us
    Plan, direct and execute all commercial objectives (both business and corporate development) that drive corporate growth in the U.S.
  • Morphosys
    President And Us Board Member
    Morphosys 2019 - 2021
    Planegg, Bayern, De
    Created a world-class oncology commercial unit and ensured enterprise excellence across commercial, sales, marketing, market access, business analytics and shared services.- Built the US subsidiary venture, including site location, talent, operational controls and leadership to enable MorphoSys AG to penetrate the US marketplace and commercialize its first asset.- Tapped an extensive oncology network to source talent and achieve commercial readiness ahead of the Prescription Drug User Fee Act for first Biological License Application approval within 17 months of hire.- Exceeded the 2020 launch year revenue by utilizing customer segmentation and new digital platforms borne out of the global pandemic.- Delivered in-line OPEX and EBIT by optimizing multi-million dollar programs, FTE, and G&A budget to maximize the impact of virtual programs.- Ran P&L with a deep understanding of the oncology market, including academic and community sites of care, Medicare Part B for infused drugs, pricing and the “buy and bill” model in US practice.- Capitalized on external relationships, including key opinion leaders, investors, and partners to ensure accurate data dissemination and scientific exchange for long-term data follow-up, which further cemented the dossier supporting the National Comprehensive Cancer network (NCCN) guideline inclusion.
  • Emd Serono, Inc.
    Senior Vice President Us Oncology Commercial
    Emd Serono, Inc. 2015 - 2019
    Boston, Massachusetts, Us
    Established Merck KGaA’s first commercial oncology footprint in the US.- Built the sales and marketing organization in preparation for its first Medicare Part B infused product launch in the emerging immune-oncology space.- Introduced the PLAIR import program to expedite product availability in the US post FDA approval.- Launched Bavencio (avelumab) for mMCC and exceeded market share goals in year one.- Prepared the organization for an additional indication in RCC.- Co-chaired the US Joint Steering Committee with Pfizer our co-commercialization partner.
  • Eisai Us
    Senior Vice President Americas Oncology Business Unit
    Eisai Us 2014 - 2015
    Nutley, Nj, Us
    Led the oncology portfolio and was instrumental in opening new markets in Brazil, Mexico and Canada.- Launched Halaven for metastatic breast cancer and was the first agent to show overall survival in late line therapy.- Exceeded launch year expectations with a significant increase in net sales. - Drove market share growth across solid tumor, hematologic, and supportive care oncology brands, including Aloxi, Dacogen, Halaven, ONTAK, Targretin, Fragmin, and Gliadel.- Spearheaded commercial readiness for Lenvima, an oral TKI for thyroid cancer and surpassed revenue expectations in the first year.
  • Eisai Us
    Vice President Oncology Business Unit
    Eisai Us 2013 - 2014
    Nutley, Nj, Us
    Headed Commercial Sales and Marketing team, and held the role of Executive member of the Americas Operating Committee.
  • Eisai Us
    Vice President Marketing And Business Operations
    Eisai Us 2011 - 2013
    Nutley, Nj, Us
    Led Marketing and Business Operations team. - Formed a co-commercialization relationship with multiple companies, including Pfizer, J&J, PriCara, Helsinn, SuperGen, MGI, Ligand and Arena Pharmaceuticals.
  • Eisai Us
    Vice President Oncology Marketing
    Eisai Us 2008 - 2011
    Nutley, Nj, Us
  • Eisai Us
    Senior Director Oncology Franchise (Sales And Marketing)
    Eisai Us 2006 - 2008
    Nutley, Nj, Us
  • Eisai Us
    Director New Products Marketing
    Eisai Us 2005 - 2006
    Nutley, Nj, Us
  • Mylan
    Senior Director Cardiovascular Marketing, Mylan Bertek Pharmaceuticals
    Mylan 2004 - 2005
    Canonsburg, Pennsylvania, Us
  • Sanofi
    Anti-Infective Product Director, Sanofi-Aventis Pharmaceuticals
    Sanofi 1986 - 2004
    Paris, France, Fr
    Promoted through a series of 11 progressive sales and product management roles over an 18 year period.

David Trexler Education Details

  • Fairleigh Dickinson University
    Fairleigh Dickinson University
    Executive Mba
  • Lenoir-Rhyne University
    Lenoir-Rhyne University
    Biology (Honors)

Frequently Asked Questions about David Trexler

What company does David Trexler work for?

David Trexler works for Ono Pharma Usa, Inc.

What is David Trexler's role at the current company?

David Trexler's current role is C-Suite Executive - BioPharma | Cancer Therapies | Patient Centric | Commercial Business Growth | Product Launch.

What is David Trexler's email address?

David Trexler's email address is da****@****sys.com

What is David Trexler's direct phone number?

David Trexler's direct phone number is (248) 373*****

What schools did David Trexler attend?

David Trexler attended Fairleigh Dickinson University, Lenoir-Rhyne University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.